top of page
< Back

Yucen Tao

PhD Student

Research interest

Discovery of new radiotheranostic

Education background

MSc. Pharm, Medicinal Chemistry, Shandong University (2022)

BSc, Pharmacy, Ningxia Medical University (2019)

Liang Zhao_edited_edited.jpg

2022 Fall


  1. Tao, Y.; Viviane, J.; Chen, X.; Zhang, J. Exploiting albumin as a versatile carrier for cancer theranostic radioligands. Acc. Chem. Res. 2023, 56, 2403-2415.

  2. Tao, Y.; Hao, X.; Ding, X.; Cherukupalli, S.; Song, Y.; Liu, X.; Zhan, P. Medicinal Chemistry Insights into Novel CDC25 Inhibitors. Eur. J. Med. Chem. 2020, 201, 112374.

  3. Tao, Y.; Hao, X.; Jing, L.; Sun, L.; Cherukupalli, S.; Liu, S.; Wu, G.; Xu, S.; Zhang, X.; Shi, X.; Song, Y.; Liu, X.; Zhan, P. Discovery of Potent and Selective Cdc25 Phosphatase Inhibitors via Rapid Assembly and In Situ Screening of Quinonoid-focused Libraries. Bioorg. Chem. 2021, 115, 105254.

  4. Tao, Y.; Xu, S.; Zhang, X; Liu, X.; Zhan, P. Editorial: Discovery of Bioactive Molecules via Miniaturized Parallel Modular Reactions and Rapid Screening (2016-2021 update). Mini Rev. Org. Chem. DOI: 10.2174/1570193X18666211111105013.

bottom of page